PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-25.99%
Negative net income growth while BB stands at 832.67%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
161.11%
Less D&A growth vs. BB's 2665.43%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-529.41%
Negative yoy deferred tax while BB stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
11.98%
SBC growth of 11.98% while BB is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
319.74%
Well above BB's 248.94% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
171.60%
AR growth of 171.60% while BB is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
124.68%
Lower 'other working capital' growth vs. BB's 350.76%. David Dodd would see fewer unexpected short-term demands on cash.
-159.56%
Both negative yoy, with BB at -28.69%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
38.24%
Operating cash flow growth below 50% of BB's 3166.10%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-15.34%
Both yoy lines negative, with BB at -1627.56%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-1000.00%
Both yoy lines negative, with BB at -212183892178005.88%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
17.71%
Some yoy expansion while BB is negative at -81.53%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-69.05%
We reduce yoy sales while BB is 412.45%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-104.84%
Both yoy lines negative, with BB at -298.33%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-55.47%
Negative yoy issuance while BB is 48.83%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-150.46%
We cut yoy buybacks while BB is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.